15th European AIDS Conference (EACS) October 2015
Oral presentations:
Where is the greatest impact of uncontrolled HIV Iinfection on clinical disease progression? presented by Amanda Mocroft on behalf of EuroSIDA in EuroCoord. PS8/6. PRESENTATION
Testing patterns and predictive value of Prostate Specific Antigen in a European HIV - positive cohort: Does size fit all? presented by Leah Shepherd on behalf of EuroSIDA in EuroCoord. PS5/5. PRESENTATION
Trends in incidences and risk factors for hepatocellular carcinoma & other liver events in HIV/HCV co-infected individuals from 2001 to 2014: a multi-cohort study, presented by Lars Iversen Gjærde (collaboration). PS7/2. PRESENTATION
Posters:
HIV/HCV-coinfection across Europe, presented by Lars Peters on behalf of EuroSIDA in EuroCoord. PE13/23. POSTER
Uptake of tenofovir-based combination antiretroviral therapy among HIV/HBV Co-infected patients in the EuroSIDA Study, presented by Lars Peters on behalf of EuroSIDA in EuroCoord. PE13/4. POSTER
Comparison of the Risk of Resistance Accumulation According to ART Switching Strategies after Virological Failure >200 Copies/mL to First cART Using the g-computation Procedure, presented by Alessandro Cozzi-Lepri on behalf of EuroSIDA in EuroCoord. PE9/11. POSTER
Inter- and intra-regional variability in the degree of ART-induced HIV-RNA suppression, presented by Kamilla Grønborg Laut on behalf of EuroSIDA in EuroCoord. PE8/71. POSTER
Long-term Virological Outcomes of ART-experienced Patients Receiving Raltegravir in a Large European Cohort Study, presented by Anna Schultze on behalf of EuroSIDA in EuroCoord. PE8/33. POSTER
Incidence of cancer in individuals treated with raltegravir-based and non-raltegravir-based cART regimens, presented by Alessandro Cozzi-Lepri on behalf of EuroSIDA in EuroCoord. PE11/9. POSTER
22nd Conference on Retroviruses and Opportunistic Infections (CROI), 23-26 February, Seattle, Washington
Posters:
A Validated Prognostic Score Estimating the Risk of Liver-Related Death Among HIV/HCV Coinfected Individuals, presented by Amanda Mocroft, submitting author: Daniel Grint. Session P-N1, February 24th 2.30-4.00 PM. Abstract number 637. POSTER
Evaluating Indicators of Standard of ART Care , presented by Kamilla Laut. Session P-K2, February 24th 2.30-4.00PM. Abstract number 561. POSTER
XXIV International Drug Resistance Workshop, 21-22 February, Seattle, Washington
Poster:
Rate of Accumulation of Drug Resistance Mutations during Virological Failure According to Different Measures of Viral Load Exposure, Presented by Anna Schultze on behalf of EuroSIDA in EuroCoord. Poster number 29. POSTER awarded the Chairman’s Poster Prize